======= UBR4 ======= == Gene Information == * **Official Symbol**: UBR4 * **Official Name**: ubiquitin protein ligase E3 component n-recognin 4 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23352|23352]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q5T4S7|Q5T4S7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=UBR4&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20UBR4|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609890|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is an E3 ubiquitin-protein ligase that interacts with the retinoblastoma-associated protein in the nucleus and with calcium-bound calmodulin in the cytoplasm. The encoded protein appears to be a cytoskeletal component in the cytoplasm and part of the chromatin scaffold in the nucleus. In addition, this protein is a target of the human papillomavirus type 16 E7 oncoprotein. [provided by RefSeq, Aug 2010]. * **UniProt Summary**: N/A No Pfam Domain information is available for this gene. |ficolin-1-rich granule membrane| |tertiary granule membrane| |specific granule membrane| |calmodulin binding| |ubiquitin-protein transferase activity| |neutrophil degranulation| |centrosome| |neutrophil activation involved in immune response| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |myeloid leukocyte activation| |proteolysis involved in cellular protein catabolic process| |cellular protein catabolic process| |leukocyte activation involved in immune response| |cell activation involved in immune response| |protein catabolic process| |protein ubiquitination| |viral process| |regulated exocytosis| |leukocyte mediated immunity| |protein modification by small protein conjugation| |symbiotic process| |exocytosis| |interspecies interaction between organisms| |zinc ion binding| |cellular macromolecule catabolic process| |leukocyte activation| |protein modification by small protein conjugation or removal| |secretion by cell| |export from cell| |macromolecule catabolic process| |organonitrogen compound catabolic process| |cell activation| |immune effector process| |secretion| |proteolysis| |organic substance catabolic process| |cellular catabolic process| |immune response| |vesicle-mediated transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp447|Amiloride 100μM R08 exp447]]|-2.13| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|-2.07| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|-1.86| |[[:results:exp125|GSK461364A 0.005μM R03 exp125]]|1.77| |[[:results:exp506|Momordin-Ic 10μM R08 exp506]]|1.78| |[[:results:exp389|PF-06409577 20μM R07 exp389]]|1.9| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|1.97| |[[:results:exp61|YM155 0.0002μM R01 exp61]]|1.99| |[[:results:exp73|LJH685 5μM R02 exp73]]|2.1| |[[:results:exp539|42°C R08 exp539]]|2.44| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|3.81| ^Gene^Correlation^ |[[:human genes:k:kcmf1|KCMF1]]|0.517| Global Fraction of Cell Lines Where Essential: 557/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|22/28| |blood|15/28| |bone|16/26| |breast|32/33| |central nervous system|41/56| |cervix|2/4| |colorectal|14/17| |esophagus|12/13| |fibroblast|1/1| |gastric|13/16| |kidney|13/21| |liver|12/20| |lung|63/75| |lymphocyte|10/16| |ovary|22/26| |pancreas|15/24| |peripheral nervous system|6/16| |plasma cell|11/15| |prostate|0/1| |skin|19/24| |soft tissue|9/9| |thyroid|2/2| |upper aerodigestive|19/22| |urinary tract|22/29| |uterus|2/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1574 * **Expression level (log2 read counts)**: 8.61 {{:chemogenomics:nalm6 dist.png?nolink |}}